Cargando…
Defining the presymptomatic phase of frontotemporal dementia
Frontotemporal dementia (FTD) is a clinically, pathologically and genetically heterogeneous disorder. Whilst disease modifying therapy trials are mostly focused on the symptomatic phase, future studies will move earlier in the disease aiming to prevent symptom onset. This review summarizes the recen...
Autores principales: | Russell, Lucy L., Rohrer, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328516/ https://www.ncbi.nlm.nih.gov/pubmed/37340685 http://dx.doi.org/10.1097/WCO.0000000000001174 |
Ejemplares similares
-
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
por: Gibson, Lucy L., et al.
Publicado: (2023) -
Amygdala subnuclei are differentially affected in the different genetic and pathological forms of frontotemporal dementia
por: Bocchetta, Martina, et al.
Publicado: (2019) -
Presymptomatic studies in genetic frontotemporal dementia
por: Rohrer, J.D., et al.
Publicado: (2013) -
Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
por: Tan, Rachel H., et al.
Publicado: (2017) -
A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia
por: Nazem, Amir, et al.
Publicado: (2018)